SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Astec LifeSciences informs about analsyt meet

18 May 2020 Evaluate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Astec LifeSciences has informed that the schedule of analysts meet as on 18th May 2020 at 11.00 am with Nippon India Mutual Fund  and Axis Capital in Mumbai. The aforesaid information is also being hosted on the website of the Company www.astecls.com.

The above information is a part of company’s filings submitted to BSE.


Astec Lifesciences Share Price

733.85 -6.55 (-0.88%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 642.30
PI Industries 3068.35
Bayer CropScience 4742.40
Sharda Cropchem 1109.75
Sumitomo Chemical 446.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×